HCS HB 95 -- CO-PAYMENTS FOR PRESCRIPTION DRUGS

SPONSOR:  Schaaf

COMMITTEE ACTION:  Voted "do pass by consent" by the Committee on
Healthcare Transformation by a vote of 10 to 0.

This substitute specifies that when the usual and customary
retail price of a prescription drug is less than the co-payment
applied by a health maintenance organization or health insurer,
the enrollee is only required to pay the usual and customary
retail price of the prescription drug and there will be no
further charge to the enrollee or plan sponsor for the
prescription.

FISCAL NOTE:  No impact on state funds in FY 2010, FY 2011, and
FY 2012.

PROPONENTS:  Supporters say that the bill gives every advantage
to the patient and addresses an issue that should be standard
practice.

Testifying for the bill were Representative Schaaf; Coventry
Health Care of Kansas, Incorporated; and United Healthcare.

OPPONENTS:  There was no opposition voiced to the committee.

Missouri House of Representatives
95th General Assembly, 1st Regular Session
Last Updated November 17, 2009 at 9:23 am